|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0535 - 0.0707|
|52 Week Range||0.0021 - 0.1300|
|Beta (5Y Monthly)||3.86|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, BC, Jan. 12, 2021 /CNW/ - Trading resumes in:Company: Pharmadrug Inc.
Toronto, Ontario--(Newsfile Corp. - January 12, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has entered into a binding letter of intent (the "LOI"), dated January 11, 2021, to acquire Sairiyo Therapeutics Inc. ("Sairiyo") (the "Acquisition"). Sairiyo is a biotechnology ...
VANCOUVER, BC, Jan. 11, 2021 /CNW/ - The following issues have been halted by IIROC:Company: Pharmadrug Inc.